Table 2: Changes in glucose level and lipid metabolism markers by alogliptin

Before administration After administration P value
HbA1c 7.4 ± 1.0 % 7.0 ± 0.7 % p< 0.0001
Non-fasting Glu 164.6 ± 39.2 mg/dL
(9.14 ± 2.18 mmol/L)
141.2 ± 35.6 mg/dL
(7.84 ± 1.98 mmol/L)
p< 0.001
LDL-C 102.9 ± 19.7 mg/dL
(2.66 ± 0.51 mmol/L)
97.9 ± 22.5 mg/dL
(2.53 ± 0.58 mmol/L)
p< 0.01
HDL-C 60.7 ± 19.3 mg/dL
(1.57 ± 0.50 mmol/L)
61.8 ± 18.3 mg/dL
(1.60 ± 0.47 mmol/L)
NS
LDL-C/HDL-C 1.83 ± 0.60 1.68 ± 0.53 P< 0.01
Non-fasting TG 137.4 ± 93.9 mg/dL
(1.55 ± 1.06 mmol/L)
116.0 ± 71.1 mg/dL
(1.31 ± 0.80 mmol/L)
p< 0.05